Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products

๐Ÿ“– Top 50% JournalFeb 22, 2023Forensic toxicology

Detection of LSD-like substances 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD, and LSZ in blotter papers

AI simplified

Abstract

Four new have been identified in paper sheet products.

  • The analogs include 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD, and LSZ.
  • 1cP-AL-LAD and 1cP-MIPLA have structural modifications at multiple positions compared to LSD.
  • The metabolic pathways and biological activities of 1cP-AL-LAD and 1cP-MIPLA remain unreported.
  • This finding marks the first detection of such LSD analogs in Japan.
  • There is concern regarding the potential future distribution of these new LSD analogs.

AI simplified

Key figures

Fig. 1
Chemical structures of LSD and seven related analog compounds.
Highlights structural variations in newly identified found in sheet drug products.
11419_2023_661_Fig1_HTML
  • Panels 1โ€“8
    Chemical structures of LSD, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD, LSZ, 1cP-LSD, and 1B-LSD are displayed with molecular bonds and atom positions.
Fig. 2
Chemical analysis of compound peak 1 from sheet A using LC-PDA-MS techniques
Highlights detailed chemical signatures of a newly identified LSD analog in using multiple analytical methods
11419_2023_661_Fig2_HTML
  • Panel a
    showing a peak at 15.94 minutes labeled as peak 1
  • Panel b
    Total ion chromatogram () with a peak at 15.97 minutes labeled as peak 1
  • Panel c
    of peak 1 with absorbance maxima at 255 nm and 294 nm
  • Panel d
    Electrospray ionization (ESI) mass spectrum of peak 1 showing a protonated molecular ion [H]+ at 418
Fig. 3
Gas chromatography-mass spectrometry data identifying a compound in sheet A
Highlights the detection and molecular signature of an LSD analog in sheet drug products using GC-MS analysis
11419_2023_661_Fig3_HTML
  • Panel a
    Total ion chromatogram () showing a prominent peak at 13.350 minutes labeled as peak 1
  • Panel b
    Electron ionization (EI) mass spectrum of peak 1 with a molecular ion peak (M+) at 417 and multiple fragment peaks
Fig. 4
and correlations of LSD analog molecules
Highlights detailed molecular connectivity in three , aiding their chemical identification.
11419_2023_661_Fig4_HTML
  • Panels 1โ€“3
    Chemical structures of 1cP-AL-LAD, 1cP-MIPLA, and 1V-LSD with arrows indicating COSY (bold lines) and HMBC (curved arrows) correlations between atoms
Fig. 5
Chemical analysis of sheet B showing chromatograms, UV spectra, and mass spectra of two peaks
Highlights distinct chromatographic and spectral profiles for two compounds in sheet B, aiding identification of
11419_2023_661_Fig5_HTML
  • Panel a
    of sheet B with two labeled peaks, 2 at 13.70 min and 2b at 15.82 min
  • Panel b
    (total ion chromatogram) of sheet B showing peaks 2 at 13.74 min and 2b at 15.84 min
  • Panel c
    of peak 2 at 13.7 min with absorbance peaks near 229, 240, and 294 nm
  • Panel d
    UV spectrum of peak 2b at 15.8 min with absorbance peaks near 256 and 295 nm
  • Panel e
    of peak 2 at 13.7 min showing a major ion at 392 ([H]+)
  • Panel f
    ESI mass spectrum of peak 2b at 15.8 min showing a major ion at m/z 392 ([M+H]+)
1 / 5

Full Text

What this is

  • Four were identified from paper sheet products in Japan.
  • These compounds include 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD, and LSZ.
  • The study utilized various mass spectrometry techniques and NMR spectroscopy for identification.

Essence

  • New were detected in sheet products, indicating ongoing changes in the landscape of designer drugs. This study marks the first identification of with multiple structural modifications in Japan.

Key takeaways

  • 1cP-AL-LAD and 1cP-MIPLA were identified as modified at multiple positions. This finding raises concerns about the emergence of new psychoactive substances in the market.
  • The study emphasizes the importance of continuous monitoring for newly distributed to address potential health risks associated with these substances.

Caveats

  • The metabolic pathways and biological activities of the identified remain unreported, which limits understanding of their effects.
  • The study was conducted on products obtained within a specific timeframe, which may not represent the entire market.

Definitions

  • LSD analogs: Compounds structurally similar to lysergic acid diethylamide (LSD) that may have psychoactive effects.

AI simplified